Clinical Trials Browser

Phase 3 × Inotuzumab Ozogamicin × Other hematologic neoplasm × Clear all

NCT03628053 2020-07-09

OBERON

Phase 3 Withdrawn

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01564784 2019-01-09

A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

Phase 3 Completed

326 enrolled 33 charts 1 FDA

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma